GlassVC

Johnson & Johnson Innovation

Corporate venture firm · Founded 1973 · New Brunswick, NJ

Johnson & Johnson's innovation arm; its venture investing unit, Johnson & Johnson Innovation – JJDC (founded in 1973 as Johnson & Johnson Development Corporation), is described as the world's longest-surviving corporate venturing program, investing across medical devices, diagnostics, pharmaceuticals and biotechnology.

Tier 4Basis: Balance-sheet CVC with no disclosed fund AUM; Tier 3 via clear sector leadership (longest-surviving healthcare CVC, 150+ active portfolio companies in 2021 per GCV) with a sourced IPO hit (Legend Biotech).

Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

This profile is unclaimed. Built from public sources. If you're a partner or employee at Johnson & Johnson Innovation, you can claim it.

Claim this profileHow claiming works

Key numbers

Assets under management

Not publicly disclosed

LAST CHECKED NOV 2026

Latest fund

Not publicly disclosed

LAST CHECKED NOV 2026

Funds

No public record

LAST CHECKED NOV 2026

Check size

Not publicly disclosed

LAST CHECKED NOV 2026

Stages

SeedSeries ASeries BGrowth

Sectors

healthcarebiotechnologymedical devicespharmaceuticals

FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG

Track record

Outcomes are recorded from public sources and attributed to the firm, not to individual partners. Shutdowns and write-offs are an ordinary part of venture investing; inclusion here is a record, not a judgment.

Hits

  • Legend Biotechipo

    Cell-therapy company backed by JJDC that listed on Nasdaq in 2020; cited in GCV's Powerlist profile of JJDC's president.

    Source: globalventuring.com

Misses

Track record

No outcomes recorded yet from public sources.

Partners 8

Reputation 1

No reputation score — basis not established for this firm.

Contact

Published sources only

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

SOURCE: FIRM WEBSITE, AS PUBLISHED 2

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Johnson & Johnson Innovation. Reviews come from founders whose identity and relationship have been verified.

Write the first review

Methodology

Tier basis — Balance-sheet CVC with no disclosed fund AUM; Tier 3 via clear sector leadership (longest-surviving healthcare CVC, 150+ active portfolio companies in 2021 per GCV) with a sourced IPO hit (Legend Biotech). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.

The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.

Source record 2

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Johnson & Johnson Innovation — provenance: GlassVC extended catalog, November 2026

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Track record · Reputation

  2. [2]

    FIRM SITE · Johnson & Johnson Innovation — Firm website, as published by the firm

    LAST CHECKED NOV 2026 ↗

    ↩ cites: Website

PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026